Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Wells Fargo cuts Gartner's price target to $140 as macro volatility tied to geopolitical tensions and AI competition ...
As Alabama lawmakers move toward compromise on utility bills, investors argue that southern company risk looks more m...
Netflix unveiled a broad price increase across every U.S. tier, with an 11% average lift. JPMorgan says the move coul...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
Disney faces a growing disney narrative problem wall as Wall Street questions leadership, strategy, and long-term pro...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
A well-known money coach’s framework meets a four-million-dollar liquidity event. The question isn’t whether the math...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
As AI headlines drive swings in tech stocks, investors ask whether Vanguard's broad tech ETF is the right pick for 20...
Berkshire Hathaway finished the year with a cash pile near 375 billion, underscoring a cautious stance that lagged br...
Applied Digital faces a turning point as it reports another quarter with a strong revenue beat but a mounting debt lo...